Hämta inspiration från verkligheten!

Hårda regler för socialt snack

Sociala medier krockar lätt med life science-branschens regelverk. Men företagen kan effektivisera sina affärer och rekrytera duktiga forskare om nätverken används rätt.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Roche Diagnostics förbereder lansering av antikroppstest

Läkemedelsföretaget Roche Diagnostics kommer lansera sitt antikroppstest mot covid-19 under maj månad. Samtidigt ska de skala upp produktionen för att i juni ku...

Tredje gästprofessorn för klimatet

Klimatforskaren Keri Facer blir Uppsala universitets tredje gästprofessor på Zennströms klimatprofessur med inriktning klimatledarskap.

Kinesisk miljardaffär för Stockholmsbolag

Specialistläkemedelsbolaget Calliditas har ingått ett licensavtal med Everest Medicines för att utveckla bolagets njurläkemedel. Avtalet är värt drygt 1 miljard kronor.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

9 steps to perfect partnering

Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...

Floppat diabetesvaccin visar positiv effekt

Nya forskningsresultat visar att Diamyd-vaccinets immunologiska effekt håller i sig fyra år efter behandling.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Fortsatt fokus på HPA

När han lämnar Scilifelab lägger Mathias Uhlén fokus på ett nytt proteomikprojekt. Dessutom fortsätter arbetet med Human Protein Atlas.